Distigmine

DB13694

small molecule experimental

Deskripsi

Distigmine is a parasympathomimetic agent with a longer duration of action and enhanced drug accumulation compared to DB00545 and DB01400. It is an anticholinergic drug and long-acting reversible carbamate cholinesterase inhibitor that binds directly and competitively to the agonist binding sites of muscurinic receptors. Distigmine is available in several countries as a treatment of underactive detrusor and voiding dysfunction in the urinary tract where the active ingredient is distigmine bromide. It improves detrusor function thereby restoring normal voiding patterns in patients suffering from detrusor underactivity A27176.

Struktur Molekul 2D

Berat 416.521
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

292 Data
Dipyridamole The therapeutic efficacy of Distigmine can be decreased when used in combination with Dipyridamole.
Ephedrine Distigmine may increase the neuromuscular blocking activities of Ephedrine.
Bambuterol Distigmine may increase the neuromuscular blocking activities of Bambuterol.
Clevidipine Distigmine may increase the neuromuscular blocking activities of Clevidipine.
Sar9, Met (O2)11-Substance P Distigmine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.
Mirabegron Distigmine may increase the neuromuscular blocking activities of Mirabegron.
Moxisylyte Distigmine may increase the neuromuscular blocking activities of Moxisylyte.
Propacetamol Distigmine may increase the neuromuscular blocking activities of Propacetamol.
Procaine Distigmine may increase the neuromuscular blocking activities of Procaine.
Cocaine Distigmine may increase the neuromuscular blocking activities of Cocaine.
Trimethaphan Distigmine may increase the neuromuscular blocking activities of Trimethaphan.
Doxacurium Distigmine may increase the neuromuscular blocking activities of Doxacurium.
Chloroprocaine Distigmine may increase the neuromuscular blocking activities of Chloroprocaine.
Tubocurarine Distigmine may increase the neuromuscular blocking activities of Tubocurarine.
Aclidinium Distigmine may increase the neuromuscular blocking activities of Aclidinium.
Butyrylthiocholine Distigmine may increase the neuromuscular blocking activities of Butyrylthiocholine.
Oxybuprocaine Distigmine may increase the neuromuscular blocking activities of Oxybuprocaine.
Benzonatate Distigmine may increase the neuromuscular blocking activities of Benzonatate.
Succinylcholine The metabolism of Succinylcholine can be decreased when combined with Distigmine.
Tramadol The therapeutic efficacy of Tramadol can be decreased when used in combination with Distigmine.
Trospium The therapeutic efficacy of Trospium can be decreased when used in combination with Distigmine.
Oxyphenonium The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Distigmine.
Butabarbital The therapeutic efficacy of Butabarbital can be decreased when used in combination with Distigmine.
Butalbital The therapeutic efficacy of Butalbital can be decreased when used in combination with Distigmine.
Benzatropine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Distigmine.
Ziprasidone The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Distigmine.
Disopyramide The therapeutic efficacy of Disopyramide can be decreased when used in combination with Distigmine.
Talbutal The therapeutic efficacy of Talbutal can be decreased when used in combination with Distigmine.
Pentobarbital The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Distigmine.
Amitriptyline The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Distigmine.
Ipratropium The therapeutic efficacy of Ipratropium can be decreased when used in combination with Distigmine.
Methadone The therapeutic efficacy of Methadone can be decreased when used in combination with Distigmine.
Olanzapine The therapeutic efficacy of Olanzapine can be decreased when used in combination with Distigmine.
Metixene The therapeutic efficacy of Metixene can be decreased when used in combination with Distigmine.
Terfenadine The therapeutic efficacy of Terfenadine can be decreased when used in combination with Distigmine.
Buclizine The therapeutic efficacy of Buclizine can be decreased when used in combination with Distigmine.
Clozapine The therapeutic efficacy of Clozapine can be decreased when used in combination with Distigmine.
Doxylamine The therapeutic efficacy of Doxylamine can be decreased when used in combination with Distigmine.
Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Distigmine.
Oxyphencyclimine The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Distigmine.
Procyclidine The therapeutic efficacy of Procyclidine can be decreased when used in combination with Distigmine.
Profenamine The therapeutic efficacy of Profenamine can be decreased when used in combination with Distigmine.
Secobarbital The therapeutic efficacy of Secobarbital can be decreased when used in combination with Distigmine.
Promazine The therapeutic efficacy of Promazine can be decreased when used in combination with Distigmine.
Hyoscyamine The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Distigmine.
Cyproheptadine The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Distigmine.
Imipramine The therapeutic efficacy of Imipramine can be decreased when used in combination with Distigmine.
Methscopolamine bromide The therapeutic efficacy of Methscopolamine bromide can be decreased when used in combination with Distigmine.
Metharbital The therapeutic efficacy of Metharbital can be decreased when used in combination with Distigmine.
Fluoxetine The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Distigmine.
Chlorpromazine The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Distigmine.
Darifenacin The therapeutic efficacy of Darifenacin can be decreased when used in combination with Distigmine.
Tridihexethyl The therapeutic efficacy of Tridihexethyl can be decreased when used in combination with Distigmine.
Triflupromazine The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Distigmine.
Dextromethorphan The therapeutic efficacy of Dextromethorphan can be decreased when used in combination with Distigmine.
Anisotropine methylbromide The therapeutic efficacy of Anisotropine methylbromide can be decreased when used in combination with Distigmine.
Nortriptyline The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Distigmine.
Amoxapine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Distigmine.
Atropine The therapeutic efficacy of Atropine can be decreased when used in combination with Distigmine.
Thiopental The therapeutic efficacy of Thiopental can be decreased when used in combination with Distigmine.
Nicardipine The therapeutic efficacy of Nicardipine can be decreased when used in combination with Distigmine.
Mecamylamine The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Distigmine.
Pirenzepine The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Distigmine.
Paroxetine The therapeutic efficacy of Paroxetine can be decreased when used in combination with Distigmine.
Homatropine methylbromide The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Distigmine.
Scopolamine The therapeutic efficacy of Scopolamine can be decreased when used in combination with Distigmine.
Isoflurane The therapeutic efficacy of Isoflurane can be decreased when used in combination with Distigmine.
Benzquinamide The therapeutic efficacy of Benzquinamide can be decreased when used in combination with Distigmine.
Clidinium The therapeutic efficacy of Clidinium can be decreased when used in combination with Distigmine.
Propiomazine The therapeutic efficacy of Propiomazine can be decreased when used in combination with Distigmine.
Propantheline The therapeutic efficacy of Propantheline can be decreased when used in combination with Distigmine.
Primidone The therapeutic efficacy of Primidone can be decreased when used in combination with Distigmine.
Dicyclomine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Distigmine.
Biperiden The therapeutic efficacy of Biperiden can be decreased when used in combination with Distigmine.
Brompheniramine The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Distigmine.
Methylphenobarbital The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Distigmine.
Quinidine The therapeutic efficacy of Quinidine can be decreased when used in combination with Distigmine.
Amantadine The therapeutic efficacy of Amantadine can be decreased when used in combination with Distigmine.
Maprotiline The therapeutic efficacy of Maprotiline can be decreased when used in combination with Distigmine.
Methantheline The therapeutic efficacy of Methantheline can be decreased when used in combination with Distigmine.
Hexafluronium The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Distigmine.
Cycrimine The therapeutic efficacy of Cycrimine can be decreased when used in combination with Distigmine.
Desloratadine The therapeutic efficacy of Desloratadine can be decreased when used in combination with Distigmine.
Glycopyrronium The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Distigmine.
Tolterodine The therapeutic efficacy of Tolterodine can be decreased when used in combination with Distigmine.
Oxybutynin The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Distigmine.
Promethazine The therapeutic efficacy of Promethazine can be decreased when used in combination with Distigmine.
Diphenhydramine The therapeutic efficacy of Diphenhydramine can be decreased when used in combination with Distigmine.
Pentolinium The therapeutic efficacy of Pentolinium can be decreased when used in combination with Distigmine.
Doxepin The therapeutic efficacy of Doxepin can be decreased when used in combination with Distigmine.
Flavoxate The therapeutic efficacy of Flavoxate can be decreased when used in combination with Distigmine.
Desipramine The therapeutic efficacy of Desipramine can be decreased when used in combination with Distigmine.
Orphenadrine The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Distigmine.
Phenobarbital The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Distigmine.
Escitalopram The therapeutic efficacy of Escitalopram can be decreased when used in combination with Distigmine.
Quetiapine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Distigmine.
Levacetylmethadol The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Distigmine.
Diphenidol The therapeutic efficacy of Diphenidol can be decreased when used in combination with Distigmine.
Aripiprazole The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Distigmine.
Chlorprothixene The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Distigmine.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 20410601
    Harada T, Fushimi K, Kato A, Ito Y, Nishijima S, Sugaya K, Yamada S: Demonstration of muscarinic and nicotinic receptor binding activities of distigmine to treat detrusor underactivity. Biol Pharm Bull. 2010;33(4):653-8.
  • PMID: 15787326
    Bougas DA, Mitsogiannis IC, Mitropoulos DN, Kollaitis GC, Serafetinides EN, Giannopoulos AM: Clinical efficacy of distigmine bromide in the treatment of patients with underactive detrusor. Int Urol Nephrol. 2004;36(4):507-12.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul